Reversing Anticoagulant Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|9|2|143-149

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.9, Iss.2, 2012-06, pp. : 143-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of Oral Anticoagulant Therapy

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

Reversing the Paradigm for Atherosclerosis Therapy: The Potential of HDL Therapeutics

By  

Pharmaceutical Innovation, Vol. 11, Iss. 6, 2002-10 ,pp. : 21-24

Adis International

Access to resources Recommend Favorite

Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia

By Glueck Charles J   Freiberg Richard A   Fontaine Robert N   Sieve-Smith Luann   Wang Ping  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1309-1316

Informa Healthcare

Access to resources Recommend Favorite

Ximelagatran: An Oral Direct Thrombin Inhibitor for Anticoagulant Therapy

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 503-506

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulant Therapy for Acute Lung Injury or Pneumonia

By  

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 315-321

Bentham Science Publishers

Access to resources Recommend Favorite